Publications

• Overdose-Related Cardiac Arrest in the Era of the Opioid Epidemic.Buckley RJ, Yang D, D'Onofrio G, Perman SM. Crit Care Clin. 2026 Jan; 2025 Sep 18. PMID: 41260714.
• Clinical profile and long-term outcomes of chest pain patients with coronary microvascular dysfunction from the emergency department - results from the Yale-CMD registry.Safdar B, Zhou B, Li F, Camici PG, Dziura J, Jastreboff AM, Lansky A, Shah SM, Sinusas A, Spatz E, D'Onofrio G. Microvasc Res. 2026 Jan; 2025 Oct 17. PMID: 41110546.
• Implementation facilitation improves readiness for emergency department-initiated buprenorphine to treat opioid use disorder.Strout T, Dziura J, Barrett TW, Cowan E, Hawk KF, Herring AA, Manteuffel J, Martel S, Owens PH, McCormack RP, Perrone J, Fiellin DA, D'Onofrio G, Edelman EJ. J Subst Use Addict Treat. 2025 Dec 5; 2025 Dec 5. PMID: 41354305.
• A diminutive tyrannosaur lived alongside Tyrannosaurus rex.Griffin CT, Bugos J, Poust AW, Morris ZS, Sombathy RS, D'Emic MD, O'Connor PM, Petermann H, Fabbri M, Colleary C. Science. 2025 Dec 4; 2025 Dec 4. PMID: 41343602.
• Alcohol and Cancer-Reply.Morford KL, Tetrault JM, O'Connor PG. JAMA. 2025 Dec 1; 2025 Dec 1. PMID: 41324920.
• Trends in and Predictors of Physician Attrition From Clinical Practice Across Specialties : A Nationwide, Longitudinal Analysis.Rotenstein LS, He Z, Dziura J, Tsugawa Y, Venkatesh AK, Melnick ER, Gettel CJ. Ann Intern Med. 2025 Dec; 2025 Oct 7. PMID: 41052447.
• Efficacy of an integrated treatment for fathers with Co-occurring substance misuse and family violence.Stover CS, Meshberg-Cohen S, Portnoy GA, Char S, McCaskill CW, Do QA, Dziura J, Martino S. Contemp Clin Trials Commun. 2025 Dec; 2025 Sep 16. PMID: 41050877.
• Reducing alcohol-associated liver disease burden in the general population.Asrani SK, Mellinger J, Sterling S, Lucey MR, Bradley KA, Bhala N, Bray J, Chen PH, DiMartini A, Fernandez A, Ghadiali M, Haque LY, Khalili M, Lee B, Lin LA, Pillai AA, Satre DD, Sengupta S, Serper M, Simonetto D, Thiele M, Welsh J, Wu T, Zsohar J, Shah VH. Lancet Gastroenterol Hepatol. 2025 Dec; 2025 Sep 18. PMID: 40976252.
• U.S. states opting out of expanded methadone take-home policies and associated mortality.Roy V, Buonora MJ, Murray-Krezan C, Fabio A, Joudrey PJ. J Subst Use Addict Treat. 2025 Dec; 2025 Sep 6. PMID: 40921251.
• Microcosting implementation facilitation for emergency department-initiated buprenorphine for untreated opioid use disorder.Ryan D, Lu T, Edelman EJ, Hawk KF, O'Connor PG, Coupet E Jr, Jalali A, Owens PH, Fiellin DA, D'Onofrio G, Murphy SM. Am J Emerg Med. 2025 Dec; 2025 Aug 12. PMID: 40865260.
• Drug Use After Emergency Department-Initiated Injectable Buprenorphine: A Secondary Analysis of the ED-INNOVATION Ancillary Safety and Feasibility Trial.Cowan E, D'Onofrio G, Perrone J, Anderson E, Dziura J, Hawk K, Herring A, McCormack R, Phadke M, Samuels EA, Fiellin DA. Acad Emerg Med. 2025 Nov 24; 2025 Nov 24. PMID: 41287157.
• Actions Needed for Pharmacy-Dispensed Methadone for Opioid Use Disorder in the United States.Weinstein ZM, Bratberg J, Joudrey PJ, Fiellin DA. J Gen Intern Med. 2025 Nov 11; 2025 Nov 11. PMID: 41217638.
• Increasing timely access to evidence-based treatment for opioid use disorder using novel digital health and system dynamics modelling approaches: a study protocol.Canty T, S Sabounchi N, Heimer R, Pantalon M, Ryus C, Buchanan L, Grewal M, Maffei J, D'Onofrio G, Heckmann R. BMJ Open. 2025 Nov 4; 2025 Nov 4. PMID: 41193189.
• Investing in Interventions to Prevent Opioid Use Disorder in Adolescents and Young Adults: Start-up Costs from NIDA's HEAL Prevention Initiative.Kuklinski MR, Gibbons BJ, Bowser DM, McCollister KE, Smart R, Dunlap LJ, Shenkar E, Bonar EE, Boomer T, Campbell M, Fiellin LE, Hutton DW, Rao V, Saldana L, Su K, Walton MA, Yilmazer T. Prev Sci. 2025 Nov; 2025 Oct 14. PMID: 41085955.
• Hepatology clinician readiness to provide addiction treatment in hepatology clinics: A mixed-methods formative evaluation.Haque LY, Choi HY, Justen M, Deng Y, Edelman EJ, Fiellin DA. Hepatol Commun. 2025 Nov 1; 2025 Oct 14. PMID: 41085538.
• Riding With Alcohol-Impaired Drivers in Fatal Crashes: Modeling Historical Trends and Future Projections Using a System Dynamics Approach.Hosseinichimeh N, MacDonald R, Li K, Fell JC, Haynie DL, Simons-Morton B, Banz BC, Camenga DR, Iannotti RJ, Curry L, Dziura J, Andersen DF, Vaca FE. J Stud Alcohol Drugs. 2025 Nov; 2025 Feb 6. PMID: 39913281.
• Prevalence and patient-level factors associated with common antibiotic allergy labels among patients undergoing hematopoietic stem cell transplants: a cross-sectional study.Belmont AP, Reynolds J, Stone CA Jr, Dziura J, Malinis M, Phillips EJ, Sarpong D, Seropian S, Edelman EJ. J Allergy Clin Immunol Pract. 2025 Oct 28; 2025 Oct 28. PMID: 41161669.
• Self-Reported Readiness-to-Change Alcohol Use in Emergency Department Patients With Alcohol Use Disorder Is Associated With Linkage to Treatment.Ryus CR, D'Onofrio G, Canty T, Pantalon MV, Heimer R, Hawk K. Ann Emerg Med. 2025 Oct 25; 2025 Oct 25. PMID: 41137848.
• Reduced social prioritization: An underlying mechanism driving slower latency to look at faces in autism.Griffin JW, Willis HC, Dommer K, Naples A, Dawson G, Jeste S, Faja S, Bernier R, Kleinhans N, Levin A, Hellemann G, Senturk D, Dziura J, Sugar C, Webb SJ, McPartland JC, Shic F. J Psychopathol Clin Sci. 2025 Oct 16; 2025 Oct 16. PMID: 41100279.
• "That would be such a game changer": A qualitative study of the acceptability and feasibility of a digital harm reduction support tool among people who use drugs.Frank D, Jawa R, Zhang C, Thompson K, Pointer T, Muggeo J, Krishnamurti T, LoPriore S, Tilley J, Joudrey PJ. Res Sq. 2025 Oct 14; 2025 Oct 14. PMID: 41282181.
• Heat exposure and drug overdose mortality in the USA.Dennett JM, Carrión D, Fiellin DA, Gonsalves GS. Addiction. 2025 Oct 6; 2025 Oct 6. PMID: 41048198.
• Disentangling informing participants from obtaining their consent.O'Rourke PP, Ali J, Carrithers J, Magnus D, Wilfond BS, Bull S, Dember LM, D'Onofrio G, Goldman J, Ho PM, Melnick ER, Staman KL, Tulsky JA, Vazquez MA, Volandes A, Wendler D. Learn Health Syst. 2025 Oct; 2025 Apr 21. PMID: 41169649.
• Pathway for a Diverse and Sustainable Emergency Medicine Clinician-Scientist Workforce: Recommendations From the 2024 SAEM Consensus Conference.Neumar RW, Boatright D, McMillian M, Corbin T, Norman MS, Vogel J, Callaway CW, Holden L, Pierce AE, Regan L, Richardson LD, Ryus CR, Adeoye O, Blomkalns A, Gerardo CJ, Kuppermann N, D'Onofrio G. Acad Emerg Med. 2025 Oct; 2025 Jul 4. PMID: 40613765.
• Intervention for hospitalized people with chronic pain and elevated risk for opioid-related harm: A pilot randomized controlled trial.Weimer MB, Buonora MJ, Hajduk AM, Ackerman AL, Daggula KR, Becker WC, Chaudhry SI, Fiellin DA. J Hosp Med. 2025 Oct; 2025 Apr 24. PMID: 40271961.
• Impact of an electronically-integrated clinical pathway on hospital initiation of medications for alcohol use disorder and subsequent hospital utilization.Cole KO, Weimer MB, Wang K, Fiellin DA, Advani AJ, Shah N, Zemaitis CT, Rhodes DJ. J Hosp Med. 2025 Oct; 2025 Apr 13. PMID: 40221929.
• Allocative efficiency analysis of strategies to reduce overdose deaths among people with opioid use disorder and history of incarceration in Connecticut.Scheidell JD, Frechette JM, Townsend TN, Zhou Q, Manandhar-Sasaki P, Fiellin DA, Heimer R, Puglisi LB, Charles DL, Su JI, Biegacki ET, Braithwaite RS. BMC Public Health. 2025 Sep 30; 2025 Sep 30. PMID: 41029627.
• Quantitative Sensory Testing of Pain in Persons with Opioid Use Disorder on Opioid Agonist Treatment: A Scoping Review.Oliveira D, Costa GPA, Fontenele R, Córdoba-Delgado MA, Funaro MC, Campbell CM, Fiellin DA, Angarita GA, De Aquino JP. Pain Med. 2025 Sep 24; 2025 Sep 24. PMID: 40990827.
• Greater readiness to cut down on drinking behaviors increases effects of a digital behavioral health intervention tool in reducing unhealthy alcohol use among Latino emergency department patients.Li K, Jolly T, Dziura J, Vaca FE. Alcohol Alcohol. 2025 Sep 16. PMID: 41020495.
• Alcohol interventions for persons with HIV: Meta-analysis of randomized controlled trials using phosphatidylethanol and self-report.Hahn JA, Kane JC, Fatch R, Espinosa da Silva C, Emenyonu NI, Scheffler A, Chirayil P, So-Armah K, Kahler CW, Conroy AA, Edelman EJ, Woolf-King S, Parry CD, Kiene SM, Chamie G, Muyindike WR, Adong J, Go VF, Cook RL, Morojele NK, Fiellin DA, Santos GM, Tahir P, Samet J, Krupitsky E, Allen IE. Drug Alcohol Depend. 2025 Sep 12; 2025 Sep 12. PMID: 40992009.
• Alcohol and Cancer Risk.Morford KL, Tetrault JM, O'Connor PG. JAMA. 2025 Sep 9. PMID: 40768234.
• An adaptive simulation intervention decreases emergency physician physiologic stress while caring for patients during COVID-19: A randomized clinical trial.Evans LV, Bonz JW, Buck S, Gerwin JN, Bonner S, Ikejiani S, Moylan T, Joseph M, de Oliveira Almeida G, Ray JM, Dziura JD, Venkatesh AK, Wong AH. PLoS One. 2025; 2025 Sep 3. PMID: 40901855.
• Predicting White Matter Hyperintensity: Leveraging Portable MRI for Accessible Brain Health Screening.Johnson IP, Brigger H, Smith J, Peasley E, Champagne A, Littig L, Lalwani D, Sze G, Payabvash S, Safdar B, D'Onofrio G, Wira C, Iglesias JE, Rosen MS, Sorby-Adams A, Kimberly WT, Sheth KN, de Havenon A. AJNR Am J Neuroradiol. 2025 Sep 2; 2025 Sep 2. PMID: 40081846.
• Medicaid: Increased Patient Access To MOUD In Residential Treatment Associated With Facility Openings And Closures, 2012-22.Beetham T, Newton H, Ndumele CD, Fiellin DA, Busch S. Health Aff (Millwood). 2025 Sep. PMID: 40893069.
• Racial, ethnic, and sex disparities in buprenorphine treatment from emergency departments by discharge diagnosis.Chhabra N, Smith D, Parde N, Hsing-Smith N, Bianco JM, Taylor RA, D'Onofrio G, Karnik NS. Acad Emerg Med. 2025 Sep; 2025 Apr 25. PMID: 40277252.
• Face perception, attention, and memory as predictors of social change in autistic children.Webb SJ, Kwan B, Bernier R, Charwarska K, Dawson G, Dziura J, Faja S, Hellmann G, Jeste S, Kleinhans N, Levin A, Naples A, Sabatos-DeVito M, Şentürk D, Shic F, Sugar C, McPartland JC. J Neurodev Disord. 2025 Aug 30; 2025 Aug 30. PMID: 40885894.
• A Measurement Science Framework to Optimize CDS for Opioid Use Disorder Treatment in the ED.Iscoe MS, Hooper CD, Levy DR, Lutz J, Paek H, Rose C, Kannampallil T, Meeker D, Dziura JD, Melnick ER. Appl Clin Inform. 2025 Aug; 2025 Aug 20. PMID: 40834872.
• Behavioral Therapy as an Adjunct to Buprenorphine Treatment for Opioid Use Disorder: A Secondary Analysis of 4 Randomized Clinical Trials.McHugh RK, Bailey AJ, McConaghy BA, Weiss RD, Fiellin DA, Hillhouse M, Moore BA, Fitzmaurice GM. JAMA Netw Open. 2025 Aug 1; 2025 Aug 1. PMID: 40833692.
• Hospital-Based Methadone and Buprenorphine Initiation Practices by Addiction Consult Services.Cohen SM, Straus E, Fiellin DA, Pomeranz JL, Suzuki J, Tetrault JM, Weimer MB, Edelman EJ, Joudrey PJ. JAMA Netw Open. 2025 Aug 1; 2025 Aug 1. PMID: 40773194.
• Coronary Artery Disease-Based Polygenic Risk Score in Early-Onset Acute Myocardial Infarction Subtypes.Dong W, Lu Y, Li SX, Sawano M, Caraballo C, Liu Y, Khera A, Philippakis A, Dreyer R, Lichtman J, D'Onofrio G, Spatz ES, Herrington D, Post WS, Rich SS, Rotter JI, Krumholz HM. JACC Adv. 2025 Aug; 2025 Jul 24. PMID: 40712269.
• Concomitant treatment of alcohol associated liver disease and alcohol use disorder in the nontransplant setting: A scoping review.Fathma S, McKee SA, Grimshaw AA, Boateng S, Fiellin DA, Haque L, Mehal WZ, Banini BA. Alcohol Clin Exp Res (Hoboken). 2025 Aug; 2025 Jul 12. PMID: 40650432.
• Receipt of addiction treatment after nonfatal opioid overdose and risk of subsequent overdose: A retrospective cohort study.Howell BA, Black A, Lin HJ, Liberatore MA, Greene CR, D'Onofrio G, Heimer R, Grau LE, Hawk K, Fiellin DA, Becker WC. Drug Alcohol Depend. 2025 Aug 1; 2025 May 13. PMID: 40413965.
• Alcohol Use Disorder Treatment Availability at Mental Health Treatment Facilities.Busch SH, Fiellin DA, Iida K, Gannon K, Weimer MB, Hockenberry J. JAMA Netw Open. 2025 Jul 1; 2025 Jul 1. PMID: 40658421.
• Racial and Ethnic Factors and Opioid Use Disorder Treatment After an Emergency Department Visit.Coupet E Jr, Chawarski MC, Hercules K, Williams JL, Murphy Ward A, Owens PH, Fiellin DA, Hawk KF, Martel SH, D'Onofrio G. JAMA Netw Open. 2025 Jul 1; 2025 Jul 1. PMID: 40658416.
• Medications for Weight Loss and MASLD: A National Survey of Hepatology and Gastroenterology Provider Practices, Attitudes, and Knowledge Before Resmetirom.Im GY, Asgharpour A, Aby ES, Stine JG, Mellinger JL, Luther J, Izzy M, Haque L, Lee BT, Cotter TG, Sherman CB, Jophlin LL, Goel A, Rice J, Chandna S, Lizaola-Mayo B, Chen PH, Singal AK, Bansal MB. J Clin Gastroenterol. 2025 Jun 23; 2025 Jun 23. PMID: 40549581.
• Health Services Usage in Patients Receiving Buprenorphine for Opioid Use Disorder or Long-Term Opioid Therapy for Chronic Pain: Retrospective Cohort Study.Savitz ST, Stevens MA, Nath B, D'Onofrio G, Melnick ER, Jeffery MM. JMIR Form Res. 2025 Jun 19; 2025 Jun 19. PMID: 40537088.
• Peer support enhanced behavioural crisis response teams in the emergency department: protocol for a stepped-wedge cluster-randomised controlled trial.Nath B, Desai R, Cook JM, Dziura JD, Davis-Plourde K, Youins R, Guy K, Pavlo AJ, Smith PE, Smith PD, Kangas K, Heckmann R, Hart L, Powsner S, Sevilla M, Evans M, Kumar A, Faustino IV, Hu Y, Bellamy C, Wong AH. BMJ Open. 2025 Jun 8; 2025 Jun 8. PMID: 40484432.
• Decline in US Drug Overdose Deaths by Region, Substance, and Demographics.Post LA, Ciccarone D, Unick GJ, D'Onofrio G, Kwon S, Lundberg AL, Sharma S, Mason M. JAMA Netw Open. 2025 Jun 2; 2025 Jun 2. PMID: 40504530.
• Hospital-Initiated Naltrexone for Alcohol Use Disorder.Weimer MB, Fiellin DA. JAMA Intern Med. 2025 Jun 1. PMID: 40257770.
• Guideline concordance of electronic health record order sets for hospital-based treatment of alcohol withdrawal syndrome.Cohen SM, Kashyap N, Steel TL, Edelman EJ, Fiellin DA, Joudrey PJ. J Hosp Med. 2025 Jun; 2024 Nov 24. PMID: 39580659.
• Predicting Agitation Events in the Emergency Department Through Artificial Intelligence.Wong AH, Sapre AV, Wang K, Nath B, Shah D, Kumar A, Faustino IV, Desai R, Hu Y, Robinson L, Meng C, Tong G, Bernstein SL, Yonkers KA, Melnick ER, Dziura JD, Taylor RA. JAMA Netw Open. 2025 May 1; 2025 May 1. PMID: 40332935.
• Relationship Between Gender Identity and Underrepresented-In-Medicine Identity on Emergency Medicine Resident Feedback.Coughlin RF, Bod J, Bonner S, Gore K, Tsyrulnik A, Devlin D, Srica N, Della-Giustina D, Phadke M, Dziura J, Goldflam K, Gottlieb M. J Emerg Med. 2025 May; 2024 Nov 24. PMID: 40288940.
• Glucagon-like peptide-1 receptor agonists, but not dipeptidyl peptidase-4 inhibitors, reduce alcohol intake.Farokhnia M, Tazare J, Pince CL, Bruns N 6th, Gray JC, Lo Re V 3rd, Fiellin DA, Kranzler HR, Koob GF, Justice AC, Vendruscolo LF, Rentsch CT, Leggio L. J Clin Invest. 2025 May 1; 2025 Mar 6. PMID: 40048376.
• State Investment in Emergency Department Buprenorphine Pays Off.D'Onofrio G, Cole JB, Perrone J. JAMA. 2025 Apr 8. PMID: 39969859.
• Longitudinal relationships between social anhedonia and internalizing symptoms in autistic children: results from the Autism Biomarkers Consortium for Clinical Trials.Gerber AH, Naples A, Chawarska K, Dawson G, Kleinhans N, Jeste S, Faja S, Dziura J, Webb S, Sugar C, Shic F, Levin AR, McPartland JC. Psychol Med. 2025 Apr 2; 2025 Apr 2. PMID: 40170613.
• "SafetyNet": Evaluation of a Recovery Coach and Paramedic Intervention Following Naloxone Resuscitation From an Opioid Overdose.Joseph D, Brokowski C, D'Onofrio G, Bogucki S, McGovern J, Allen R, Dziura J, Cone DC, Pantalon MV. Subst Use Addctn J. 2025 Apr; 2024 Aug 22. PMID: 39171791.
• Health System, Community-Based, or Usual Dementia Care for Persons With Dementia and Caregivers: The D-CARE Randomized Clinical Trial.Reuben DB, Gill TM, Stevens A, Williamson J, Volpi E, Lichtenstein M, Jennings LA, Galloway R, Summapund J, Araujo K, Bass D, Weitzman L, Tan ZS, Evertson L, Yang M, Currie K, Green AS, Godoy S, Abraham S, Reese J, Samper-Ternent R, Hirst RM, Borek P, Charpentier P, Meng C, Dziura J, Xu Y, Skokos EA, He Z, Aiudi S, Peduzzi P, Greene EJ. JAMA. 2025 Mar 18. PMID: 39878968.
• Psychedelics for Cancer Pain and Associated Psychological Distress: A Narrative Review of a Potential Strategy.Belitzky E, Ravani Carvalho LV, Taylor M, Ortiz CN, Baum L, Fiellin DA, Lustberg MB. Cancer Med. 2025 Mar. PMID: 40052631.
• Cost-Effectiveness of Implementation Facilitation to Promote Emergency Department-Initiated Buprenorphine for Opioid Use Disorder.Lu T, Ryan D, Cadet T, Chawarski MC, Coupet E, Edelman EJ, Hawk KF, Huntley K, Jalali A, O'Connor PG, Owens PH, Martel SH, Fiellin DA, D'Onofrio G, Murphy SM. Ann Emerg Med. 2025 Mar; 2024 Nov 20. PMID: 39570250.
• Clinician and Practice Characteristics Associated With Support of Office-based Methadone: Findings From a National Survey.Sung ML, Black AC, Blevins D, Henry BF, Cates-Wessel K, Dawes MA, Hagle H, Joudrey PJ, Molfenter T, Levin FR, Fiellin DA, Edelman EJ. J Addict Med. 2025 Mar-Apr 01; 2024 Oct 30. PMID: 39475119.
• Clinician-caregiver informant discrepancy is associated with sex, diagnosis age, and intervention use among autistic children.Azu MA, Han GT, Wolf JM, Naples AJ, Chawarska K, Dawson G, Bernier RA, Jeste SS, Dziura JD, Webb SJ, Sugar CA, Shic F, McPartland JC. Autism. 2025 Mar; 2024 Sep 30. PMID: 39344965.
• Adaptive decision support for addiction treatment to implement initiation of buprenorphine for opioid use disorder in the emergency department: protocol for the ADAPT Multiphase Optimization Strategy trial.Iscoe MS, Diniz Hooper C, Levy DR, Buchanan L, Dziura J, Meeker D, Taylor RA, D'Onofrio G, Oladele C, Sarpong DF, Paek H, Wilson FP, Heagerty PJ, Delgado MK, Hoppe J, Melnick ER. BMJ Open. 2025 Feb 20; 2025 Feb 20. PMID: 39979056.
• Depression and Low Social Support Mediate the Association of Marital Stress and 12-Month Cardiac-Specific Quality of Life in Young Adults With Acute Myocardial Infarction.Zhu C, Dreyer RP, Li F, Spatz ES, Caraballo C, Mahajan S, Raparelli V, Leifheit EC, Lu Y, Krumholz HM, Spertus JA, D'Onofrio G, Pilote L, Lichtman JH. Biopsychosoc Sci Med. 2025 Feb-Mar 01. PMID: 39909011.
• The Feasibility and Acceptability of a Clinical Pharmacist-delivered Intervention to Reduce Bothersome Health Symptoms from Polypharmacy and Alcohol Use and Communicate Risk among People with HIV: Pilot Study Protocol.Womack JA, Leblanc MM, Sager AS, Zaets LN, Maisto SA, Garcia A, Aoun-Barakat L, Brown SE, Edelman EJ, Fiellin DA, Fisher J, Fraenkel L, Kidwai-Khan F, Marconi VC, Martino S, Pulk R, Satre DD, Virata M, Justice AC, Hsieh E. AIDS Behav. 2025 Feb; 2024 Oct 28. PMID: 39465468.
• Machine Learning-Based Prediction of Death and Hospitalization in Patients With Implantable Cardioverter Defibrillators.Rosman L, Lampert R, Wang K, Gehi AK, Dziura J, Salmoirago-Blotcher E, Brandt C, Sears SF, Burg M. J Am Coll Cardiol. 2025 Jan 7; 2024 Nov 20. PMID: 39570241.
• Adolescent extracurricular activities and perception of risk of harm from binge drinking.Szapary C, Meyer J, Fernandes CF, Pendergrass Boomer T, Fiellin L, Aneni K. PLOS Ment Health. 2025; 2025 Apr 9. PMID: 40510398.
• A Prehospital Quality Improvement Framework to Reduce Mortality and Other Harms Associated with Opioid Use Disorder.Glenn M, Crowe R, Dorsett M, Taigman M, Herring AA, Mercer M, Joiner A, Venkatesh A, Davis C, Hawk K, Hern HG, Carroll G, Cabañas JG, D'Onofrio G, Samuels EA. Prehosp Emerg Care. 2025; 2024 Dec 13. PMID: 39671519.
• Integrated Stepped Alcohol Treatment With Contingency Management for Unhealthy Alcohol Use Among People With HIV: A Randomized Controlled Trial.Edelman EJ, Dziura J, Deng Y, DePhilippis D, Ferguson T, Brown S, Marconi VC, Goetz MB, Rodriguez-Barradas MC, Simberkoff MS, Molina PE, Weintrob AC, Maisto SA, Paris M, Justice AC, Bryant KJ, Fiellin DA. J Acquir Immune Defic Syndr. 2025 Jan 1. PMID: 39321757.
• Spatiotemporal Eye Movement Dynamics Reveal Altered Face Prioritization in Early Visual Processing Among Autistic Children.Griffin JW, Naples A, Bernier R, Chawarska K, Dawson G, Dziura J, Faja S, Jeste S, Kleinhans N, Sugar C, Webb SJ, Shic F, McPartland JC. Biol Psychiatry Cogn Neurosci Neuroimaging. 2025 Jan; 2024 Sep 3. PMID: 39237004.
• Stepped Care for Patients to Optimize Whole Recovery (SC-POWR): An Effectiveness Trial Evaluating a Stepped Care Model for Individuals With Opioid Use Disorder and Chronic Pain.Rossi R, Cutter CJ, Beitel M, Covelli M, Fiellin DA, Kerns RD, Vassilieva S, Olabisi D, Barry DT. Subst Use Addctn J. 2025 Jan; 2024 Apr 12. PMID: 38606900.
• Four targets: an enhanced framework for guiding causal inference from observational data.Lu H, Li F, Lesko CR, Fink DS, Rudolph KE, Harhay MO, Rentsch CT, Fiellin DA, Gonsalves GS. Int J Epidemiol. 2024 Dec 16. PMID: 39868475.
• Take-Home Naloxone, Release From Jail, and Opioid Overdose-A Piece of the Puzzle.Balter DR, Howell BA. JAMA Netw Open. 2024 Dec 2; 2024 Dec 2. PMID: 39656464.
• Integrated and collaborative care across the spectrum of alcohol-associated liver disease and alcohol use disorder.Haque LY, Leggio L. Hepatology. 2024 Dec 1; 2024 Jun 27. PMID: 38935926.
• Availability of Medications for Opioid Use Disorder in US Psychiatric Hospitals.Cohen SM, Beetham T, Fiellin DA, Muvvala SB. JAMA Netw Open. 2024 Nov 4; 2024 Nov 4. PMID: 39535800.
• Recommendations for monitoring adherence and fidelity in pragmatic trials based on experience in the Pain Management Collaboratory.Dziura J, Gilstad-Hayden K, Coffman CJ, Long CR, Yu Q, Buta E, Coggeshall S, Geda M, Peduzzi P, Kyriakides TC. Pain Med. 2024 Nov 1. PMID: 39514878.
• Screening, brief intervention, and referral to treatment for pain management for veterans separating from military service: study protocol of a hybrid type 2 study testing implementation facilitation versus training-as-usual.Sellinger JJ, Rosen MI, Lazar CM, Gilstad-Hayden K, Dziura J, Li FY, Mattocks K, Weede A, Sullivan-Tibbs M, Rose L, Garcia Vassallo G, Manhapra A, Turner A, Vogt D, Woodward EN, Hartmann CW, Haskell SG, Mohammad A, Martino S. Pain Med. 2024 Nov 1. PMID: 39514877.
• Utility of the PICOTS framework to assess clinical trial disruptions: monitoring the impact of COVID-19 in the Pain Management Collaboratory.Peduzzi P, Brandt C, Dearth CL, Dziura J, Farrokhi S, George SZ, Kyriakides TC, Long CR, Mascha EJ, Patterson CG, Rhon DI, Kerns RD. Pain Med. 2024 Nov 1. PMID: 39514876.
• Adapting to change: experiences and recommendations from the Pain Management Collaboratory on modifying statistical analysis plans.Yu Q, George SZ, Kyriakides TC, Rhon DI, Morasco BJ, Dziura J, Fritz JM, Geda M, Peduzzi P, Long CR. Pain Med. 2024 Nov 1. PMID: 39514871.
• A Validated Algorithm to Identify Hepatic Decompensation in the Veterans Health Administration Electronic Health Record System.Haque LY, Tate JP, Chew M, Caniglia EC, Taddei TH, Re VL 3rd. Pharmacoepidemiol Drug Saf. 2024 Nov. PMID: 39477692.
• Epidemiology and Health Care Burden of Alcohol Use Disorder.Choi HY, Balter DR, Haque LY. Clin Liver Dis. 2024 Nov; 2024 Jul 23. PMID: 39362708.
• Prescription Opioid Dose Change Before Fatal Opioid-Detected Overdose.Kazemitabar M, Howell BA, Becker WC, Lin HJ, Grau LE, Heimer R, D'Onofrio G, Hawk K, Fiellin DA, Black AC. J Stud Alcohol Drugs. 2024 Nov; 2024 May 22. PMID: 38775307.
• Using Phosphatidylethanol as an Adjunct to Self-Reported Alcohol Use Improves Identification of Liver Fibrosis Risk.Murnane PM, Afshar M, Chamie G, Cook RL, Ferguson T, Haque LY, Jacobson KR, Justice AC, Kim TW, Khalili M, Krupitsky E, McGinnis KA, Molina P, Muyindike WR, Myers B, Richards VL, So-Armah K, Stewart S, Sulkowski MS, Tien PC, Hahn JA. Am J Gastroenterol. 2024 Oct 31; 2024 Oct 31. PMID: 39480054.
• Asynchronous education improves emergency medical services clinician confidence and knowledge in caring for patients near the end-of-life.Wang DH, Dunn C, Brooten JK, Gacioch B, Taigman M, He Z, Dziura J, Breyre AM. J Am Coll Emerg Physicians Open. 2024 Oct; 2024 Oct 23. PMID: 39449818.
• Harming Health by Imposing In-Prison Co-Payments.Howell BA, Resnik J, Wang EA. JAMA Intern Med. 2024 Oct 1. PMID: 39102228.
• Trends and Disparities in Initiation of Buprenorphine in US Emergency Departments, 2013-2022.Chhabra N, Smith D, Dickinson G, Caglianone L, Taylor RA, D'Onofrio G, Karnik NS. JAMA Netw Open. 2024 Sep 3; 2024 Sep 3. PMID: 39325455.
• Treatment Failure Versus Failed Treatments: The Risks of Embracing Treatment Refractory Addiction.Fiellin DA. J Addict Med. 2024 Sep-Oct 01; 2024 Aug 10. PMID: 39356618.
• Postrelease Risk of Overdose and All-Cause Death Among Persons Released From Jail or Prison: Minnesota, March 2020-December 2021.Hill K, Bodurtha PJ, Winkelman TNA, Howell BA. Am J Public Health. 2024 Sep; 2024 Jul 18. PMID: 39024534.
• Treatment for Co-Occurring Stimulant and Opioid Use Disorders: Overcoming Barriers in the Era of Polysubstance Use.Howell BA, Lin LA, Coughlin LN. JAMA Psychiatry. 2024 Sep 1. PMID: 38985457.
• Parsing evoked and induced gamma response differences in Autism: A visual evoked potential study.Dickinson A, Ryan D, McNaughton G, Levin A, Naples A, Borland H, Bernier R, Chawarska K, Dawson G, Dziura J, Faja S, Kleinhans N, Sugar C, Senturk D, Shic F, Webb SJ, McPartland JC, Jeste S. Clin Neurophysiol. 2024 Sep; 2024 Jun 8. PMID: 38959536.
• Buprenorphine-naloxone vs. extended-release naltrexone for opioid use disorder in individuals with and without criminal legal involvement: A secondary analysis of the X:BOT randomized controlled trial.Balter DR, Puglisi LB, Dziura J, Fiellin DA, Howell BA. J Subst Use Addict Treat. 2024 Sep; 2024 Jun 8. PMID: 38857827.
• Opportunities for Alcohol-Related Care in the COVID-19 Pandemic and Beyond.Oldfield B, Haque L, Jennifer Edelman E. J Gen Intern Med. 2024 Sep. PMID: 38671202.
• Understanding social situations: study protocol for a randomized controlled trial evaluating a novel social cognitive training versus modified problem-solving training for people with psychosis.Fiszdon JM, Bell MD, Fulford D, Roberts DL, Dziura J, Parente L, Nasse A, Choi J. Front Psychiatry. 2024; 2024 Aug 22. PMID: 39238934.
• Vigorous Exercise in Patients With Congenital Long QT Syndrome: Results of the Prospective, Observational, Multinational LIVE-LQTS Study.Lampert R, Day S, Ainsworth B, Burg M, Marino BS, Salberg L, Tome Esteban MT, Abrams DJ, Aziz PF, Barth C, Behr ER, Bell C, Berul CI, Bos JM, Bradley D, Cannom DS, Cannon BC, Concannon MA, Cerrone M, Czosek RJ, Dubin AM, Dziura J, Erickson CC, Estes NAM 3rd, Etheridge SP, Goldenberg I, Gray B, Haglund-Turnquist C, Harmon K, James CA, Johnsrude C, Kannankeril P, Lara A, Law IH, Li F, Link MS, Molossi SM, Olshansky B, Noseworthy PA, Saarel EV, Sanatani S, Shah M, Simone L, Skinner J, Tomaselli GF, Ware JS, Webster G, Zareba W, Zipes DP, Ackerman MJ. Circulation. 2024 Aug 13; 2024 Jul 25. PMID: 39051104.
• Modeling of drinking and driving behaviors among adolescents and young adults in the United States: Complexities and Intervention outcomes.Hosseinichimeh N, MacDonald R, Li K, Fell JC, Haynie DL, Simons-Morton B, Banz BC, Camenga DR, Iannotti RJ, Curry LA, Dziura J, Andersen DF, Vaca FE. Soc Sci Med. 2024 Aug; 2024 Jul 5. PMID: 39043064.
• Management of alcohol-associated liver disease and alcohol use disorder in liver transplant candidates and recipients: Challenges and opportunities.Sharma P, Shenoy A, Shroff H, Kwong A, Lim N, Pillai A, Devuni D, Haque LY, Balliet W, Serper M. Liver Transpl. 2024 Aug 1; 2024 Mar 13. PMID: 38471008.
• Extended-Release 7-Day Injectable Buprenorphine for Patients With Minimal to Mild Opioid Withdrawal.D'Onofrio G, Herring AA, Perrone J, Hawk K, Samuels EA, Cowan E, Anderson E, McCormack R, Huntley K, Owens P, Martel S, Schactman M, Lofwall MR, Walsh SL, Dziura J, Fiellin DA. JAMA Netw Open. 2024 Jul 1; 2024 Jul 1. PMID: 38976265.
• Using qualitative system dynamics modeling to understand overdose bystander behavior in the context of Connecticut's Good Samaritan Laws and identify effective policy options.Thompson RL, Sabounchi NS, Ali SS, Heimer R, D'Onofrio G, Heckmann R. Harm Reduct J. 2024 Jun 27; 2024 Jun 27. PMID: 38937759.
• An Introduction and Practical Guide to Strategies for Analyzing Longitudinal Data in Clinical Trials of Smoking Cessation Treatment: Beyond Dichotomous Point-Prevalence Outcomes.Kypriotakis G, Bernstein SL, Bold KW, Dziura JD, Hedeker D, Mermelstein RJ, Weinberger AH. Nicotine Tob Res. 2024 Jun 21. PMID: 38214037.
• Trends in the Prescribing of Buprenorphine for Opioid Use Disorder, 2019-2023.Savitz ST, Stevens MA, Nath B, D'Onofrio G, Melnick ER, Jeffery MM. Mayo Clin Proc Innov Qual Outcomes. 2024 Jun; 2024 May 24. PMID: 38841599.
• The MATE Act: Progress for substance use education, but is checking a box enough?Morford KL, Tetrault JM, Fiellin DA. J Gen Intern Med. 2024 Jun; 2024 Feb 2. PMID: 38308156.
• Alcohol-Related Care Among Veterans With Unhealthy Alcohol Use: The Role of Long-Term Opioid Therapy Receipt.Joudrey PJ, Wang M, DeRycke E, Williams EC, Edelman EJ. J Addict Med. 2024 May-Jun 01; 2024 Mar 27. PMID: 38533996.